Key Findings

The study reports the identification of a novel VIM-type metallo-beta-lactamase, VIM-19, in clinical isolates of Enterobacteriaceae from Algeria. VIM-19 differs from VIM-1 by two amino acid substitutions and exhibits broad-spectrum hydrolytic activity against β-lactam antibiotics.